Genomic analysis, immunomodulation and deep phenotyping of patients with nodding syndrome
Brain · 2023
DOI: 10.1093/brain/awac357 ↗Kurz gefasst
Fachartikel in der Zeitschrift Brain, 2023. Verfasst von Ariane Soldatos und 32 weiteren Autor:innen. Beteiligte Einrichtung: National Institutes of Health Intramural Research Program, Bethesda, MD 20892, USA. Hauptthemen laut MEDLINE: Nodding Syndrome, Onchocerciasis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Mentored Clinical Scientist Development, Centers for Disease Control and Prevention, Ministry of Health.
Abstract (Originalsprache)
The aetiology of nodding syndrome remains unclear, and comprehensive genotyping and phenotyping data from patients remain sparse. Our objectives were to characterize the phenotype of patients with nodding syndrome, investigate potential contributors to disease aetiology, and evaluate response to immunotherapy. This cohort study investigated members of a single-family unit from Lamwo District, Uganda. The participants for this study were selected by the Ugandan Ministry of Health as representative for nodding syndrome and with a conducive family structure for genomic analyses. Of the eight family members who participated in the study at the National Institutes of Health (NIH) Clinical Center, three had nodding syndrome. The three affected patients were extensively evaluated with metagenomic sequencing for infectious pathogens, exome sequencing, spinal fluid immune analyses, neurometabolic and toxicology testing, continuous electroencephalography and neuroimaging. Five unaffected family members underwent a subset of testing for comparison. A distinctive interictal pattern of sleep-activated bursts of generalized and multifocal epileptiform discharges and slowing was observed in two patients. Brain imaging showed two patients had mild generalized cerebral atrophy, and both patients and unaffected family members had excessive metal deposition in the basal ganglia. Trace metal biochemical evaluation was normal. CSF was non-inflammatory and one patient had CSF-restricted oligoclonal bands. Onchocerca volvulus-specific antibodies were present in all patients and skin snips were negative for active onchocerciasis. Metagenomic sequencing of serum and CSF revealed hepatitis B virus in the serum of one patient. Vitamin B6 metabolites were borderline low in all family members and CSF pyridoxine metabolites were normal. Mitochondrial DNA testing was normal. Exome sequencing did not identify potentially causal candidate gene variants. Nodding syndrome is characterized by a distinctive pattern of sleep-activated epileptiform activity. The associated growth stunting may be due to hypothalamic dysfunction. Extensive testing years after disease onset did not clarify a causal aetiology. A trial of immunomodulation (plasmapheresis in two patients and intravenous immunoglobulin in one patient) was given without short-term effect, but longer-term follow-up was not possible to fully assess any benefit of this intervention.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- National Institutes of Health Intramural Research Program, Bethesda, MD 20892, USA.
- Centers for Disease Control and Prevention, Atlanta, GA 30329, USA.
- University of California San Francisco, San Francisco, CA 94143, USA.
- Weill Institute for Neurosciences, University of California San Francisco, San Francisco, CA 94158, USA.
- Chan Zuckerberg Biohub, San Francisco, CA 94158, USA.
- Ministry of Health, Kampala, Republic of Uganda.
ORCID-Profile: Ariane Soldatos, Tory Johnson, Michael R Wilson, Avindra Nath
Förderung
- Mentored Clinical Scientist Development
- Centers for Disease Control and Prevention
- Ministry of Health
- Intramural Research Programs of NINDS
- NHGRI
- NIH Office of the Director
- Chan Zuckerberg Initiative
- National Institute of Neurological Disorders and Stroke
Zitieren
APA
Soldatos, A., Nutman, T. B., Johnson, T., Dowell, S. F., Sejvar, J. J., Wilson, M. R., DeRisi, J. L., Inati, S. K., Groden, C., Evans, C., O'Connell, E. M., Toliva, B. O., Aceng, J. R., Aryek-Kwe, J., Toro, C., Stratakis, C. A., Buckler, A. G., Cantilena, C., Palmore, T. N., …, & Nath, A. (2023). Genomic analysis, immunomodulation and deep phenotyping of patients with nodding syndrome. Brain. https://doi.org/10.1093/brain/awac357
Vancouver
Soldatos A, Nutman TB, Johnson T, Dowell SF, Sejvar JJ, Wilson MR, et al. Genomic analysis, immunomodulation and deep phenotyping of patients with nodding syndrome. Brain. 2023. doi:10.1093/brain/awac357
BibTeX
@article{Soldatos2023,
author = {Soldatos, Ariane and Nutman, Thomas B and Johnson, Tory and Dowell, Scott F and Sejvar, James J and Wilson, Michael R and DeRisi, Joseph L and Inati, Sara K and Groden, Catherine and Evans, Colleen and O'Connell, Elise M and Toliva, Bernard Opar and Aceng, Jane R and Aryek-Kwe, Josephine and Toro, Camilo and Stratakis, Constantine A and Buckler, A Gretchen and Cantilena, Cathy and Palmore, Tara N and Thurm, Audrey and Baker, Eva H and Chang, Richard and Fauni, Harper and Adams, David and Macnamara, Ellen F and Lau, C Christopher and Malicdan, May Christine V and Pusey-Swerdzewski, Barbara and Downing, Robert and Bunga, Sudhir and Thomas, Jerry D and Gahl, William A and Nath, Avindra},
title = {Genomic analysis, immunomodulation and deep phenotyping of patients with nodding syndrome},
journal = {Brain},
year = {2023},
doi = {10.1093/brain/awac357}
}
EUVIMED